Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference

Rhea-AI Summary

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology firm, announced Dr. Jennifer Buell's participation in a fireside chat at the Jefferies 2020 Virtual London Healthcare Conference on November 17, 2020, from 4:25 PM - 4:55 PM GMT. This event will highlight the company’s innovative pipeline of immune therapies, including checkpoint antibodies and vaccines aimed at enhancing immune responses against cancer. Interested parties can register for the webinar and access a replay on the Agenus website.

LEXINGTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Jennifer Buell, President and COO of Agenus, will participate in a fireside chat at the Jefferies 2020 Virtual London Healthcare Conference on Tuesday, November 17, 2020 from 4:25 PM – 4:55 PM GMT / 11:25 AM – 11:55 AM EST.

Registration for the webinar can be done in advance at https://wsw.com/webcast/jeff141/agen/1816875.

A replay will be available after the call on the Events & Presentations page of the Agenus website at https://investor.agenusbio.com/events-and-presentations.

About Agenus
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com and our Twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and Twitter.

Contact:
Agenus Inc. 
Caroline Bafundo
212-994-8209
Caroline.Bafundo@agenusbio.com

FAQ

What is the date and time of Agenus' fireside chat at the Jefferies Conference?

The fireside chat will take place on November 17, 2020, from 4:25 PM to 4:55 PM GMT.

Who will represent Agenus at the Jefferies 2020 Virtual London Healthcare Conference?

Dr. Jennifer Buell, President and COO of Agenus, will participate in the discussion.

How can I register for the Agenus webinar?

You can register for the webinar in advance through the link provided in the press release.

Where can I find the replay of the Agenus fireside chat?

A replay will be available on the Events & Presentations page of the Agenus website after the event.

What is the focus of Agenus as a company?

Agenus focuses on developing immuno-oncology therapies that engage the immune system to combat cancer.